Open menu

RSS Subscribe to our Nanotechnology Business News feed

Tekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections

Tekmira Pharmaceuticals Corporation, a leader in RNA interference (RNAi) therapeutics, announced today that, together with collaborators at The University of Texas Medical Branch, it has been awarded a new United States National Institutes of Health (NIH) grant to support research to develop RNAi therapeutics to treat Ebola and Marburg hemorrhagic fever viral infections using Tekmira's lipid nanoparticle (LNP) delivery technology.

Posted: Oct 15th, 2010

Read more

Veeco Announces Asia Expansion Plan

At the 7th China International Forum for Solid State Lighting, John R. Peeler, Chief Executive Officer of Veeco Instruments Inc., announced a significant expansion of Veeco's Asia presence.

Posted: Oct 14th, 2010

Read more

DFI Secures Bid On Large-Scale New York City High-Rise Project

Diamon-Fusion International, Inc., global developer and exclusive licensor of patented hydrophobic nanotechnologies, announced today the company along with its partner, New York Poly Steel, has secured a bid for a large-scale coating project for the original Tiffany and Co. building at 15 Union Square Street in New York City.

Posted: Oct 13th, 2010

Read more